Skip to content

Inpatient Self Monitoring and Administration Study (ISMAS)

Inpatient Self Monitoring and Administration Study (ISMAS)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00506272
Acronym
ISMAS
Enrollment
1
Registered
2007-07-25
Start date
2007-12-31
Completion date
Unknown
Last updated
2015-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Hyperglycemia, Hypoglycemia

Keywords

diabetes mellitus, hyperglycemia, hypoglycemia, self care

Brief summary

ISMAS is designed to test the hypothesis that self management of insulin dependent diabetes mellitus by selected patients admitted for elective surgery is more efficacious than standard care with respect to overall glycemic control, attaining finger-stick blood sugars, and administering insulin.

Interventions

PROCEDUREStandard care

finger-stick blood glucose values to be obtained and all insulin administration to be delivered by nursing staff

PROCEDURESelf blood glucose monitoring and insulin administration

Patients will monitor blood glucose using a hand-held blood glucose monitor, and self-administer insulin

Sponsors

Atlanta VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female, age \< 80 2. Most recent hemoglobin A1C within the past 6 months \< 12% 3. Recent history of regular self-administered peripheral blood glucose checks as an outpatient 4. Recent history of insulin self-administration at least twice a day as an outpatient 5. Admitted for a hospitalization anticipated to last at least 3 days 6. Mini Mental Status Examination (MMSE) ≥ 25 at admission and the same or better post-operatively 7. All patients will be actively followed by the Endocrinology inpatient consultation team during the hospitalization.

Exclusion criteria

1. Currently receiving peritoneal or hemodialysis 2. Patients with unstable angina 3. History of myocardial infarction within 3 weeks prior to enrollment 4. Current admission due to or associated with altered mental status or encephalopathy 5. History of an episode of altered mental status or encephalopathy within the 4 weeks prior to enrollment 6. A confirmed diagnosis of dementia 7. Inability to self-adjust insulin 8. No recent history of ability to perform regular peripheral blood glucose checks 9. Frequency of hypoglycemia (\< 60 mg/dL) \> twice/week by history 10. Inability to eat without assistance 11. Study objectives will not be pursued in patients during stays in any intensive care unit.

Design outcomes

Primary

MeasureTime frame
number of blood glucose measurements obtained/number of blood glucose measurements orderedpatients will be followed for the duration of hospital stay, an expected average of 5 days
number of insulin doses administered/number of insulin doses prescribedpatients will be followed for the duration of hospital stay, an expected average of 5 days
average blood glucosepatients will be followed for the duration of hospital stay, an expected average of 5 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026